Structures of soluble rabbit neprilysin complexed with phosphoramidon or thiorphan

Neutral endopeptidase (neprilysin; NEP) is a proteinase that cleaves a wide variety of peptides and has been implicated in Alzheimer's disease, cardiovascular conditions, arthritis and other inflammatory diseases. The structure of the soluble extracellular domain (residues 55 – 750) of rabbit neprilysin was solved both in its native form at 2.1   Å resolution, and bound to the inhibitors phosphoramidon and thiorphan at 2.8 and 3.0   Å resolution, respectively. Consistent with the extracellular domain of human neprilysin, the structure reveals a large central cavity which contains the active site and the location for inhibitor binding.
Source: Acta Crystallographica Section F - Category: Biochemistry Authors: Tags: neutral endopeptidase neprilysin phosphoramidon thiorphan research communications Source Type: research

Related Links:

This study, for the first time, shows that transplantation of non-autologous mitochondria from healthy skeletal muscle cells into normal cardiomyocytes leads to short-term improvement of bioenergetics indicating "supercharged" state. However, over time these improved effects disappear, which suggests transplantation of mitochondria may have a potential application in settings where there is an acute stress. Outlining Some of the Science Behind Partial Reprogramming at Turn.bio https://www.fightaging.org/archives/2020/03/outlining-some-of-the-science-behind-partial-reprogramming-at-turn-bio/ Tur...
Source: Fight Aging! - Category: Research Authors: Tags: Newsletters Source Type: blogs
Abstract Understanding the mechanisms that control the body's response to inflammation is of key importance, due to its involvement in myriad medical conditions, including cancer, arthritis, Alzheimer's disease and asthma. While resolving inflammation has historically been considered a passive process, since the turn of the century the hunt for novel therapeutic interventions has begun to focus upon active manipulation of constituent mechanisms, particularly involving the roles of apoptosing neutrophils, phagocytosing macrophages and anti-inflammatory mediators. Moreover, there is growing interest in how inflammat...
Source: Bulletin of Mathematical Biology - Category: Bioinformatics Authors: Tags: Bull Math Biol Source Type: research
Dear Carol: My mom, age 79, has had steadily declining health for several years. Arthritis is a genetic problem in my family, so pain is an issue. Besides that, she has severe asthma, so her lungs show a lot of deterioration. The family has handled all of this but now her thinking is getting foggy. She’s resisted moving to assisted living even though we all know that this would probably be best. I work full time, so even though I live in her community, I can’t be with her all the time. I also have teenage kids so even checking on Mom every day is getting to be too much. I know that I’m just getting starte...
Source: Minding Our Elders - Category: Geriatrics Authors: Source Type: blogs
The importance of the kynurenine pathway in normal immune system function has led to an appreciation of its possible contribution to autoimmune disorders such as rheumatoid arthritis. Indoleamine-2,3-dioxygenase (IDO) activity exerts a protective function, limiting the severity of experimental arthritis, whereas deletion or inhibition exacerbates the symptoms. Other chronic disorder with an inflammatory component, such as atherosclerosis, are also suppressed by IDO activity. It is suggested that this overall anti-inflammatory activity is mediated by a change in the relative production or activity of Th17 and regulatory T c...
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research
(American Chemical Society) It seems too good to be true: a single drug that could treat humanity's worst afflictions, including atherosclerosis, cancer, Alzheimer's, Parkinson's and arthritis. All of these diseases have one thing in common -- they involve an inflammatory protein called NLRP3. Now, biotech start-ups and pharmaceutical companies are racing to develop drugs that inhibit the function of this protein, according to an article inChemical&Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society.  
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
Photo credit Niklas Hamann  “My mom is 81 and lives alone in her condo,” Judy Hanson writes. “Her arthritis is painful, but she gets around with a walker. Her mind is okay for now, though she is sometimes forgetful. I also feel that she is lonely. “I’m worried about her safety and have been telling her for several years that she needs help,” she continues. “I’m not proud to say that I’ve stooped to yelling at her, but I have done it. I hate the thought of her falling and not having help, and I also think she’d be happier with more company. There’s ...
Source: Minding Our Elders - Category: Geriatrics Authors: Source Type: blogs
AbstractNext-generation sequencing has enabled patient selection for targeted drugs, some of which have shown remarkable efficacy in cancers that have the cognate molecular signatures. Intriguingly, rapidly emerging data indicate that altered genes representing oncogenic drivers can also be found in sporadic non-malignant conditions, some of which have negligible and/or low potential for transformation to cancer. For instance, activatingKRAS mutations are discerned in endometriosis and in brain arteriovenous malformations, inactivatingTP53 tumor suppressor mutations in rheumatoid arthritis synovium, andAKT,MAPK, andAMPK pa...
Source: Genome Medicine - Category: Genetics & Stem Cells Source Type: research
Calpain is a Ca2+-activated, heterodimeric cysteine protease consisting of a large catalytic subunit and a small regulatory subunit. Dysregulation of this enzyme is involved in a range of pathological conditions such as cancer, Alzheimer's disease and rheumatoid arthritis, and thus calpain I is a drug target with potential therapeutic applications. Difficulty in the production of this enzyme has hindered structural and functional investigations in the past, although heterodimeric calpain I can be generated by Escherichia coli expression in low yield. Here, an unexpected structure discovered during crystallization trials of...
Source: Acta Crystallographica Section F - Category: Biochemistry Authors: Tags: calpain expression Hfq chaperones cysteine protease research communications Source Type: research
In conclusion, this study suggests that epigenetic age acceleration is significantly associated with lung function in women older than 50 years. We hypothesised that this could be due to menopause. However, we have observed that menopause has minimal effect and therefore there is possibility of other unknown physiological factors at older age in females mediating the epigenetic age acceleration effect on lung function. While, it is still unknown what exactly epigenetic aging from DNA methylation measures, this study suggests it can be utilised as one of the important factors to assess women's lung health in old age. DNA me...
Source: Fight Aging! - Category: Research Authors: Tags: Newsletters Source Type: blogs
AbstractTumor necrosis factor receptor 1 (TNFR1) is a transmembrane receptor that plays a key role in the regulation of the inflammatory pathway. While inhibition of TNFR1 has been the focus of many studies for the treatment of autoimmune diseases such as rheumatoid arthritis, activation of the receptor is important for the treatment of immunodeficiency diseases such as HIV and neurodegenerative diseases such as Alzheimer's disease where a boost in immune signaling is required. In addition, activation of other TNF receptors such as death receptor 5 or FAS receptor is important for cancer therapy. Here, we used a previously...
Source: Protein Science - Category: Biochemistry Authors: Tags: Article Source Type: research
More News: Alzheimer's | Arthritis | Biochemistry | Cardiology | Cardiovascular | Heart | Rheumatology